Glutamic Acid Decarboxylase (GAD-65) Autoimmunity Associated With Profound Daytime Hypersomnia, Nighttime Insomnia, Mild Autonomic Neuropathy and Axonal Sensori-Motor Polyneuropathy: A Case Report on a New Phenotype

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2020 Nov 26

PMID 33240708

Authors

Hassan Kesserwani

Affiliations

Soon will be listed here.

Abstract

We describe the case of a 74-year-old fit and healthy man who developed a profound sleep disorder characterized by mid-day hypersomnia and debilitating insomnia. A wide range of therapies, including a large number of stimulants and hypnotics with multiple different mechanisms of action, failed to improve his condition. Trials with oral prosthetic devices and a wide range of face masks with positive pressure assistance and multiple continuous positive airway pressure (CPAP) titration studies failed to help. Along with his sleep disorder, our patient developed a slowly evolving axonal sensorimotor polyneuropathy with a subtle autonomic neuropathy. Due to the latter two conditions, a comprehensive paraneoplastic panel was obtained and revealed extremely high titer glutamic acid decarboxylase (GAD-65) autoantibodies. This was confirmed by three independent laboratories and by cerebrospinal fluid staining of rat hippocampus, revealing the classic tram-track lines along the dentate gyrus. Our patient was treated empirically with intravenous immunoglobulin. We believe that our case reveals a unique syndrome related to GAD-65 autoantibodies and adds to the growing list of GAD-65 associated diseases. This case is particularly provocative as it raises the idea to check for GAD-65 autoimmunity in patients who suffer from a profound sleep disorder resistant to conventional treatment.

References

Fileccia E, Rinaldi R, Liguori R, Incensi A, DAngelo R, Giannoccaro M . Post-ganglionic autonomic neuropathy associated with anti-glutamic acid decarboxylase antibodies. Clin Auton Res. 2016; 27(1):51-55. DOI: 10.1007/s10286-016-0390-6. View

Maier A, Mannartz V, Wasmuth H, Trautwein C, Neumann U, Weis J . GAD Antibodies as Key Link Between Chronic Intestinal Pseudoobstruction, Autonomic Neuropathy, and Limb Stiffness in a Nondiabetic Patient: A CARE-Compliant Case Report and Review of the Literature. Medicine (Baltimore). 2015; 94(31):e1265. PMC: 4616576. DOI: 10.1097/MD.0000000000001265. View

Dade M, Berzero G, Izquierdo C, Giry M, Benazra M, Delattre J . Neurological Syndromes Associated with Anti-GAD Antibodies. Int J Mol Sci. 2020; 21(10). PMC: 7279468. DOI: 10.3390/ijms21103701. View

Bien C, Vincent A, Barnett M, Becker A, Blumcke I, Graus F . Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain. 2012; 135(Pt 5):1622-38. DOI: 10.1093/brain/aws082. View

Iranzo A . Sleep and neurological autoimmune diseases. Neuropsychopharmacology. 2019; 45(1):129-140. PMC: 6879573. DOI: 10.1038/s41386-019-0463-z. View

McKeon A, Robinson M, McEvoy K, Matsumoto J, Lennon V, Ahlskog J . Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012; 69(2):230-8. DOI: 10.1001/archneurol.2011.991. View

Sabharwal P, Mahmoudi M, Berberi N, Vasquez B, Friedman D, Kothare S . A Case of Recurrent Insomnia: Extending the Spectrum of Autoimmune Encephalitis. J Clin Sleep Med. 2016; 12(5):763-5. PMC: 4865564. DOI: 10.5664/jcsm.5814. View

Graus F, Saiz A, Dalmau J . GAD antibodies in neurological disorders - insights and challenges. Nat Rev Neurol. 2020; 16(7):353-365. DOI: 10.1038/s41582-020-0359-x. View

Munoz-Lopetegi A, de Bruijn M, Boukhrissi S, Bastiaansen A, Nagtzaam M, Hulsenboom E . Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment. Neurol Neuroimmunol Neuroinflamm. 2020; 7(3). PMC: 7136051. DOI: 10.1212/NXI.0000000000000696. View

10.

Rout U, Michener M, Dhossche D . GAD65 autoantibodies in Kleine-Levin syndrome. J Neuropsychiatry Clin Neurosci. 2014; 26(2):E49-51. DOI: 10.1176/appi.neuropsych.13050110. View

11.

Ben Achour N, Ben Younes T, Rebai I, Ben Ahmed M, Kraoua I, Youssef-Turki I . Severe dysautonomia as a main feature of anti-GAD encephalitis: Report of a paediatric case and literature review. Eur J Paediatr Neurol. 2018; 22(3):548-551. DOI: 10.1016/j.ejpn.2018.01.004. View

12.

McKeon A, Tracy J . GAD65 neurological autoimmunity. Muscle Nerve. 2017; 56(1):15-27. DOI: 10.1002/mus.25565. View

13.

Walikonis J, Lennon V . Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc. 1998; 73(12):1161-6. DOI: 10.4065/73.12.1161. View

14.

Kraichely R, Farrugia G, Pittock S, Castell D, Lennon V . Neural autoantibody profile of primary achalasia. Dig Dis Sci. 2009; 55(2):307-11. PMC: 2819289. DOI: 10.1007/s10620-009-0838-9. View

15.

Gresa-Arribas N, Arino H, Martinez-Hernandez E, Petit-Pedrol M, Sabater L, Saiz A . Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. PLoS One. 2015; 10(3):e0121364. PMC: 4361655. DOI: 10.1371/journal.pone.0121364. View

16.

Arino H, Hoftberger R, Gresa-Arribas N, Martinez-Hernandez E, Armangue T, Kruer M . Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies. JAMA Neurol. 2015; 72(8):874-81. PMC: 4838033. DOI: 10.1001/jamaneurol.2015.0749. View

17.

Silber M . Autoimmune sleep disorders. Handb Clin Neurol. 2016; 133:317-26. DOI: 10.1016/B978-0-444-63432-0.00018-9. View

18.

Pittock S, Yoshikawa H, Ahlskog J, Tisch S, Benarroch E, Kryzer T . Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc. 2006; 81(9):1207-14. DOI: 10.4065/81.9.1207. View

19.

Dalakas M . Progress and stiff challenges in understanding the role of GAD-antibodies in stiff-person syndrome. Exp Neurol. 2013; 247:303-7. DOI: 10.1016/j.expneurol.2013.02.010. View